FDA Warning Letter — Fresenius Medical Care Renal Therapies Group, LLC

Case 666791 — FEI 3001451489

The FDA took a Warning Letter action against Fresenius Medical Care Renal Therapies Group, LLC on December 4, 2023 (Waltham, MA). The action was issued by CDRH and concerns devices products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Fresenius Medical Care Renal Therapies Group, LLC
Date
December 4, 2023
Fiscal Year
2024
Product Type
Devices
Center
CDRH
Location
Waltham, MA (United States)